Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Abbott
MedTech
Abbott nabs approvals for ICD lead
Abbott has received both FDA and CE Mark approval for its UltiSynq defibrillation lead tech.
Patrick McGuire
Nov 11, 2026 1:25am
Abbott trial looks to shift artery disease treatment
Nov 3, 2026 7:08am
Abbott to separate Nutrition biz into an independent company
Oct 22, 2026 8:32am
Abbott update allows heart readings to be seen at home
Oct 6, 2026 11:08am
Abbott launches SimpleScreen CRC blood test in the US
Oct 2, 2026 2:17am
Abbott garners FDA nod for its TactiFlex catheter to treat AFib
Sep 9, 2026 8:09am